×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MXCT – maxcyte, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MXCT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/15
08:30 am
mxct
MaxCyte: Strong Revenues, Fast-Growing Cell-Therapy Market, Very Low Share Price [Seeking Alpha]
Medium
Report
MaxCyte: Strong Revenues, Fast-Growing Cell-Therapy Market, Very Low Share Price [Seeking Alpha]
3/12
09:11 am
mxct
MaxCyte, Inc. (NASDAQ: MXCT) was given a new $6.00 price target on by analysts at BTIG Research. They now have a "buy" rating on the stock.
Low
Report
MaxCyte, Inc. (NASDAQ: MXCT) was given a new $6.00 price target on by analysts at BTIG Research. They now have a "buy" rating on the stock.
3/12
08:05 am
mxct
MaxCyte, Inc. (NASDAQ: MXCT) had its price target lowered by analysts at Stifel Nicolaus from $11.00 to $9.00. They now have a "buy" rating on the stock.
Medium
Report
MaxCyte, Inc. (NASDAQ: MXCT) had its price target lowered by analysts at Stifel Nicolaus from $11.00 to $9.00. They now have a "buy" rating on the stock.
3/11
07:54 pm
mxct
MaxCyte, Inc. (MXCT) Q4 2024 Earnings Call Transcript [Seeking Alpha]
Low
Report
MaxCyte, Inc. (MXCT) Q4 2024 Earnings Call Transcript [Seeking Alpha]
3/11
04:54 pm
mxct
MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance [Yahoo! Finance]
Low
Report
MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance [Yahoo! Finance]
3/11
04:05 pm
mxct
MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance
Medium
Report
MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance
2/12
03:58 am
mxct
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs [Yahoo! Finance]
Low
Report
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs [Yahoo! Finance]
2/12
02:00 am
mxct
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
Low
Report
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/20
06:49 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 18 Filed by: Soleymannezhad Ali
Medium
Report
Form 4 MAXCYTE, INC. For: Mar 18 Filed by: Soleymannezhad Ali
3/20
06:48 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 18 Filed by: Sandoval David I.
Medium
Report
Form 4 MAXCYTE, INC. For: Mar 18 Filed by: Sandoval David I.
3/20
06:08 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 18 Filed by: Swirsky Douglas J
Medium
Report
Form 4 MAXCYTE, INC. For: Mar 18 Filed by: Swirsky Douglas J
3/18
08:51 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 14 Filed by: Soleymannezhad Ali
Low
Report
Form 4 MAXCYTE, INC. For: Mar 14 Filed by: Soleymannezhad Ali
3/18
08:50 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 14 Filed by: Sandoval David I.
Low
Report
Form 4 MAXCYTE, INC. For: Mar 14 Filed by: Sandoval David I.
3/18
08:33 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 14 Filed by: Swirsky Douglas J
Low
Report
Form 4 MAXCYTE, INC. For: Mar 14 Filed by: Swirsky Douglas J
3/18
08:31 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 14 Filed by: Masoud Maher
Low
Report
Form 4 MAXCYTE, INC. For: Mar 14 Filed by: Masoud Maher
3/11
05:06 pm
mxct
Form 10-K MAXCYTE, INC. For: Dec 31
Low
Report
Form 10-K MAXCYTE, INC. For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: